Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP928753.RAuvMr0IUVzQVv7r1Wo4NxREAJe0X86EJ57HTQ4a6uFFk130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928753.RAuvMr0IUVzQVv7r1Wo4NxREAJe0X86EJ57HTQ4a6uFFk130_provenance.
• NP462866.RAvZ_MVWnzNN_otIyQGYvU-PEjTtmWp45Sb6lQznZjdjc130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462866.RAvZ_MVWnzNN_otIyQGYvU-PEjTtmWp45Sb6lQznZjdjc130_provenance.
• NP855225.RAv8dXI4PwsvQfZqLhUqdNXFLLPXq1NVACu2-U8F8Tt6k130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855225.RAv8dXI4PwsvQfZqLhUqdNXFLLPXq1NVACu2-U8F8Tt6k130_provenance.
• NP33096.RAbev97yREpSqgKX6kgAjPa177Kyhv08J110ph1OtH6-g130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33096.RAbev97yREpSqgKX6kgAjPa177Kyhv08J110ph1OtH6-g130_provenance.
• NP731084.RA-lGMcxLVgHfOFLDdjYIx8FikJ0n1aFvbACCSmHVxK_g130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731084.RA-lGMcxLVgHfOFLDdjYIx8FikJ0n1aFvbACCSmHVxK_g130_provenance.
• NP865186.RA7nPm3VqaVSPgYPUWi2JhdoDNlTHvJ7YS_I3axuoqg1E130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865186.RA7nPm3VqaVSPgYPUWi2JhdoDNlTHvJ7YS_I3axuoqg1E130_provenance.
• NP7471.RA6yZjgj0oGMtEnD-huKS1LmtG3bbzDmcy9Ic72cKz1Vw130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7471.RA6yZjgj0oGMtEnD-huKS1LmtG3bbzDmcy9Ic72cKz1Vw130_provenance.
• NP25274.RA94z8-BlnU2YZoS60XxRh5UvvTJo12SQ6s8WLGztP9gM130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP25274.RA94z8-BlnU2YZoS60XxRh5UvvTJo12SQ6s8WLGztP9gM130_provenance.
• NP18097.RAvk1AJ4aMaciethwWO2lJgCk3wwpI9AdWPyNb6dj2XCI130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18097.RAvk1AJ4aMaciethwWO2lJgCk3wwpI9AdWPyNb6dj2XCI130_provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP33560.RAWTk8BBsiHm_hw95h1BqtYogGvQ4iQrm4G85nAvoCQSs130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33560.RAWTk8BBsiHm_hw95h1BqtYogGvQ4iQrm4G85nAvoCQSs130_provenance.
• NP33561.RAddz00FyIaCzl0DxSlym-Uq4mDivgp2iV6W5idGrZL-M130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33561.RAddz00FyIaCzl0DxSlym-Uq4mDivgp2iV6W5idGrZL-M130_provenance.
• NP33564.RASzbLMdCSMybKydDTjADMATmY2VhgY5endLGD9HkhA3Q130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33564.RASzbLMdCSMybKydDTjADMATmY2VhgY5endLGD9HkhA3Q130_provenance.
• NP33565.RAdx4fmKTgUY0SjcJJvRSac4R0PCQ6hVSZumk_1z1zPpQ130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33565.RAdx4fmKTgUY0SjcJJvRSac4R0PCQ6hVSZumk_1z1zPpQ130_provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP18106.RAHo7n1InNil9-7G-kIKgxHf0pqA0mi-cgyxG90pxnFNI130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18106.RAHo7n1InNil9-7G-kIKgxHf0pqA0mi-cgyxG90pxnFNI130_provenance.
• NP1124531.RAekvm-LySu4Rc5cRlColsCa3anbTHzZlpJR7J8WjPUaY130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124531.RAekvm-LySu4Rc5cRlColsCa3anbTHzZlpJR7J8WjPUaY130_provenance.
• NP8001.RALzbeuRUqbJCsaKHP29qBaYQL58TPPHRQwEB7LNH_0Gk130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8001.RALzbeuRUqbJCsaKHP29qBaYQL58TPPHRQwEB7LNH_0Gk130_provenance.
• NP33562.RAhVV231MdOkVs8GfGpqLs98fkRn1UpWxjB7p8n9xr1VM130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33562.RAhVV231MdOkVs8GfGpqLs98fkRn1UpWxjB7p8n9xr1VM130_provenance.
• NP33563.RAJNV2TQREuRXTdJZJ-2YZdhZ4zI6gc0tmTR9zK2WUW4c130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33563.RAJNV2TQREuRXTdJZJ-2YZdhZ4zI6gc0tmTR9zK2WUW4c130_provenance.
• NP917050.RA-vssGudDXz_ygF7FQp2bRgoEwu1S3j0TT-029pBZRbQ130_assertion description "[Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917050.RA-vssGudDXz_ygF7FQp2bRgoEwu1S3j0TT-029pBZRbQ130_provenance.